Bacterial Diagnostics in Aquaculture Market Size, Share & Trends Analysis Report By Animal Type (Mackerel, Carps, Milkfish, Sea Bream, Sea Bass, Trout, Crustaceans, And Other Species), By Technique, By Distribution Channel (Aquarium Stores, E-Commerce, And Company Stores), By Region, And By Segment Forecasts, 2023-2031.
The Bacterial Diagnostics in Aquaculture Market Size is valued at USD 3.76 Bn in 2022 and is predicted to reach USD 6.46 Bn by the year 2031 at a 6.4% CAGR during the forecast period for 2023-2031. Finding and quantifying bacterial pathogens in aquatic systems is known as bacterial diagnostics in aquaculture. Bacterial diagnostics in aquaculture is a crucial aspect of managing and maintaining the health of aquatic organisms, particularly in fi...
Report ID: 2056 |
Delivery: Immediate |
Published: October 2024 |
No. of Pages: 180
Drug Formulary Management Market Share & Trends Analysis Report, By Type (Open Formulary, Closed Formulary, and Controlled Formulary), By Application Type (Hospital Formulary Management and Managed Care Organization (MCO) Formulary Management), By Region, and Segment Forecasts, 2023-2031
Drug Formulary Management Market Size is predicted to grow at a 5.9% CAGR during the forecast period for 2024-2031. Drug formulary management is a system used in healthcare to ensure that patients are prescribed the safest, most effective, and most affordable medications. It's essentially a list of approved medications that a healthcare organization, like a hospital or insurance plan, recommends for use by doctors. This list is based on scient...
Report ID: 2532 |
Delivery: Immediate |
Published: October 2024 |
No. of Pages: 180
Oligonucleotide Therapy Market Size, Share & Trends Analysis Report By Type (Antisense, Ribozymes, Aptamers, miRNA, CpG/Immunostimulatory, RNAi), By Application (Infectious Diseases, Oncology, Neurodegenerative Disorders, Cardiovascular Diseases, Kidney Diseases, Others), By End User (Hospitals, Research Institutes, Others), By Region, And By Segment Forecasts, 2024-2031.
Oligonucleotide Therapy Market Size is valued at USD 5.21 billion in 2023 and is predicted to reach USD 19.92 billion by the year 2031 at a 18.6% CAGR during the forecast period for 2024-2031. Oligonucleotides are some of the most promising therapeutic mechanisms for a range of hard-to-treat diseases, in particular those caused by genetic mutations. These are Short sequences of artificially created DNA or RNA molecules that attach to matching ...
Report ID: 2566 |
Delivery: Immediate |
Published: October 2024 |
No. of Pages: 180
Retinoic Acid Pathway Therapeutics Market Size, Share and Growth Analysis 2026 to 2035
Global Retinoic Acid Pathway Therapeutics Market Size is predicted to grow at an 7.4% CAGR during the forecast period for 2024-2031. The Retinoic Acid Pathway Therapeutics Market Size, Share & Trends Analysis Distribution by Product Type (Retinoic Acid Receptor Agonists (RAR Agonists), Retinoid X Receptor Agonists (RXR Agonists), RAR and RXR Dual Agonists, Others (Novel/Next-Generation Retinoic Acid Derivatives)), Application, Route of Admin...
Report ID: 2816 |
Delivery: Immediate |
Published: October 2024 |
No. of Pages: 170
Synthetic Blood Substitute Market, Share & Trends Analysis Report, By Application (Cardiovascular Diseases, Malignant Neoplasma, Injuries, Neonatal Conditions, Organ Transplant, Maternal Condition), By End-use, By Product, By Source, By Component, By Configuration, By Region, and Segment Forecasts, 2024-2031
The Synthetic Blood Substitute Market Size is valued at USD 7.26 Bn in 2023 and is predicted to reach USD 20.75 Bn by the year 2031 at an 14.3% CAGR during the forecast period for 2024-2031. The global synthetic blood substitute industry is rapidly evolving, focusing on the development of artificial blood products to overcome the limitations of traditional blood transfusions. These substitutes aim to address issues such as blood type compatibi...
Report ID: 2798 |
Delivery: Immediate |
Published: September 2024 |
No. of Pages: 170
Catastrophic Antiphospholipid Syndrome Market Size, Share & Trends Analysis Report, By Treatment (Anticoagulants, Immunosuppressive Therapy, Plasma Exchange Therapy, Intravenous Immunoglobulin (IVIG) and Others), By End-use (Hospitals, Clinics, Others), By Region, Forecasts, 2024-2031
The Catastrophic Antiphospholipid Syndrome Market Size was valued at USD 4.38 Bn in 2023 and is predicted to reach USD 9.34 Bn by 2031 at a 10.2% CAGR during the forecast period for 2024-2031. Catastrophic antiphospholipid syndrome refers to an uncommon immunological condition marked by persistent antiphospholipid antigens, chronic arterial or venous embolism, and reproductive mortality. It is more common in women and may develop as eithe...
Report ID: 2786 |
Delivery: Immediate |
Published: September 2024 |
No. of Pages: 165
Longevity and Anti-Senescence Therapy Market Size, Share & Trends Analysis Report By Therapy (Senolytic Drug Therapy, Gene Therapy, Cell Therapy, Mitochondrial Therapy, Immunotherapy, Others), By Application, By Region, And By Segment Forecasts, 2024-2031
The Longevity and Anti-Senescence Therapy Market Size is valued at USD 2,736.43 million in 2023 and is predicted to reach USD 4,121.54 million by the year 2030 at a 6.8 % CAGR during the forecast period for 2024-2030. Longevity is an effective approach focuses on the extension of health span by slowing the rate of aging. This approach is considered as the most efficient way to combat various aging-related chronic illnesses and disabling condit...
Report ID: 1354 |
Delivery: Immediate |
Published: September 2024 |
No. of Pages: 185
Oligonucleotide Delivery System Market Size, Share & Trends Analysis Distribution by Delivery System (Conjugation-Based Delivery Systems (GALNAc Conjugation, Ligand Conjugation, Antibody Conjugation, Targeting Moiety Conjugation), Nanoparticle-Based Delivery Systems (Lipid Nanoparticles (LNPs), Peptide Nanoparticles), Viral Vector-Based Delivery Systems (Adeno-associated Virus (AAV) Vectors, AAV9, Lentiviral Vectors, Others), Exosome-Based Delivery Systems, Liposomes, Others), Disease Indication and Segment Forecasts, 2024-2031
The Oligonucleotide Delivery System Market is predicted to grow at an 12.4% CAGR during the forecast period for 2024-2031. The delivery system of an oligonucleotide refers to the method and technologies applied for transferring oligonucleotides into cells where they could exert their therapeutic effects. Oligonucleotides, due to their size and chemical properties, face the challenge of penetration through the biological barriers to enter targe...
Report ID: 2779 |
Delivery: Immediate |
Published: September 2024 |
No. of Pages: 165
Lipid-Based Drug Delivery Systems Market Size, Share & Trends Analysis Distribution by Type of Lipid-Based System (Liposomes, Solid Lipid Nanoparticles (SLNs), Nanostructured Lipid Carriers (NLCs), Lipid Nanoparticles (LNPs), Micelles, Lipid-Polymer Hybrid Systems), Application, Route of Administration, Formulation and Segment Forecasts, 2024-2031
The Lipid-Based Drug Delivery Systems Market Size is predicted to grow with a an CAGR of 11.9% during the forecast period for 2024-2031. Lipid-based drug delivery systems (LBDDS) are intended to increase the delivery and efficacy of drugs that are poorly soluble in water. These systems employ lipids as carriers to promote drug bioavailability, resulting in greater absorption in the body. LBDDS are employed in a variety of pharmaceutical applic...
Report ID: 2764 |
Delivery: Immediate |
Published: September 2024 |
No. of Pages: 180
Bioactive Formulation for Functional F&B Market, Share & Trends Analysis Report, By Ingredient Type (Prebiotics, Probiotics, Adaptogens, Polyphenols, Omega-3 Fatty Acids, Antioxidants), By Formulation Technology (Encapsulation, Microemulsions, Liposomal Delivery), By Application, By Region, and Segment Forecasts, 2024-2031
The Bioactive Formulation for Functional F&B Market is predicted to grow at an 8.31% CAGR during the forecast period for 2024-2031. Bioactive formulations in functional food and beverages (F&B) utilize biologically active compounds that provide health benefits beyond basic nutrition. These formulations typically include ingredients such as polyphenols, prebiotics, probiotics, vitamins, peptides, and dietary fibers, which are targeted at...
Report ID: 2736 |
Delivery: Immediate |
Published: September 2024 |
No. of Pages: 180
Pharmaceuticals